IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

MFN Partners Management, LP

Q1 2019 Holdings

Filed 2019-05-14 | 15 holdings | $9.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aclaris Therapeutics Inc(ACRS)COM00461U105$9.0M1,500,00093.6%
Allergan PLCSHSG0177J108$95.2K650,1011.0%
FOX Corp(FOXA)CL A COM35137L105$87.0K2,369,3310.9%
PG&E Corp(PCG)COM69331C108$71.2K4,000,0000.7%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$66.8K4,939,5410.7%
Cheniere Energy Inc(LNG)COM NEW16411R208$51.3K750,0000.5%
Bristol Myers Squibb Co(BMY)CallCOM110122108$47.7K1,000,0000.5%
XPO Logistics Inc(XPO)COM983793100$45.4K845,5000.5%
GTT Communications IncCOM362393100$34.7K1,000,0000.4%
Goldman Sachs Group Inc(GS)COM38141G104$33.4K173,8110.3%
Pioneer NAT RES Co(PXDEUR)COM723787107$30.5K200,0000.3%
FGL HldgsORD SHSG3402M102$23.6K3,000,0000.2%
Takeda Pharmaceutical Co LTD(TAK)SPONSORED ADS874060205$16.0K785,0000.2%
Navient Corporation(NAVI)COM63938C108$7.5K650,0000.1%
Revance Therapeutics Inc(RVNCEUR)COM761330109$72546,0000.0%